Search research articles
Contact Us
Filters
Showing results (151-160 of 191) with videos related to
Page
of 20
Sort By:
Lung Cancer (Amsterdam, Netherlands)
|
June 1, 1997
Pretreatment minimal staging and prognostic factors for non-small cell lung cancer
R Feld, R Abratt, S Graziano, et al.
American Journal of Clinical Oncology
|
October 1, 1985
Short course prophylactic cranial irradiation for small cell lung cancer
R Feld, G H Clamon, R Blum, et al.
Annals of Internal Medicine
|
October 1, 1987
Superiority of alternating non-cross-resistant chemotherapy in extensive small cell lung cancer. A multicenter, randomized clinical trial by the National Cancer Institute of Canada
W K Evans, R Feld, N Murray, et al.
Archives of Internal Medicine
|
June 1, 1985
A multicenter comparative trial of tobramycin and ticarcillin vs moxalactam and ticarcillin in febrile neutropenic patients
R Feld, T J Louie, L Mandell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1989
Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients
P Ruffie, R Feld, S Minkin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 16, 2000
The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients
J Klastersky, M Paesmans, E B Rubenstein, et al.
Antimicrobial Agents and Chemotherapy
|
August 1, 1988
Cefoperazone compared with ampicillin plus tobramycin for severe biliary tract infections
M G Bergeron, J Mendelson, G K Harding, et al.
Clinical Colorectal Cancer
|
November 28, 2002
The palliative benefit of irinotecan in 5-fluorouracil-refractory colorectal cancer: its prospective evaluation by a Multicenter Canadian Trial
M Michael, D Hedley, A Oza, et al.
The Journal of Infectious Diseases
|
September 1, 1989
Once-daily therapy with ceftriaxone compared with daily multiple-dose therapy with cefotaxime for serious bacterial infections: a randomized, double-blind study
L A Mandell, M G Bergeron, A R Ronald, et al.
Annals of Internal Medicine
|
September 1, 1984
Changes in body composition in patients with small-cell lung cancer. The effect of total parenteral nutrition as an adjunct to chemotherapy
M Shike, D M Russel, A S Detsky, et al.
Page
of 20
Search research articles
Search
Showing results (151-160 of 191) with videos related to
Sort By:
Page
of 20
Lung Cancer (Amsterdam, Netherlands)
|
June 1, 1997
Pretreatment minimal staging and prognostic factors for non-small cell lung cancer
R Feld, R Abratt, S Graziano, et al.
American Journal of Clinical Oncology
|
October 1, 1985
Short course prophylactic cranial irradiation for small cell lung cancer
R Feld, G H Clamon, R Blum, et al.
Annals of Internal Medicine
|
October 1, 1987
Superiority of alternating non-cross-resistant chemotherapy in extensive small cell lung cancer. A multicenter, randomized clinical trial by the National Cancer Institute of Canada
W K Evans, R Feld, N Murray, et al.
Archives of Internal Medicine
|
June 1, 1985
A multicenter comparative trial of tobramycin and ticarcillin vs moxalactam and ticarcillin in febrile neutropenic patients
R Feld, T J Louie, L Mandell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1989
Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients
P Ruffie, R Feld, S Minkin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 16, 2000
The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients
J Klastersky, M Paesmans, E B Rubenstein, et al.
Antimicrobial Agents and Chemotherapy
|
August 1, 1988
Cefoperazone compared with ampicillin plus tobramycin for severe biliary tract infections
M G Bergeron, J Mendelson, G K Harding, et al.
Clinical Colorectal Cancer
|
November 28, 2002
The palliative benefit of irinotecan in 5-fluorouracil-refractory colorectal cancer: its prospective evaluation by a Multicenter Canadian Trial
M Michael, D Hedley, A Oza, et al.
The Journal of Infectious Diseases
|
September 1, 1989
Once-daily therapy with ceftriaxone compared with daily multiple-dose therapy with cefotaxime for serious bacterial infections: a randomized, double-blind study
L A Mandell, M G Bergeron, A R Ronald, et al.
Annals of Internal Medicine
|
September 1, 1984
Changes in body composition in patients with small-cell lung cancer. The effect of total parenteral nutrition as an adjunct to chemotherapy
M Shike, D M Russel, A S Detsky, et al.
Page
of 20